Press release from Companies: DanCann Pharma A/S: Capital reduction in DanCann Pharma A/S is completed

Press release from Companies: Minutes of extraordinary general meeting

Press release from Companies: DanCann Pharma A/S: Calls for an Extraordinary General Meeting regarding New Authorizations and Reduction of Share Capital in Preparation for Reverse Stock Split

Press release from Companies: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

Press release from Companies: DanCann Pharma A/S: Number of Reported Suspected Adverse Reactions Drops by Two-Thirds in 2023 Despite 72% Growth in the Medicinal Cannabis Pilot Programme

Press release from Companies: DanCann Pharma A/S: Quarterly CEO Reflection

Press release from Companies: DanCann Pharma A/S: Quarterly CEO Reflection

Press release from Companies: DanCann Pharma A/S Publishes Q2-2024 Report: Record Revenue and First-Ever Positive EBITDA

Press release from Companies: DanCann Pharma A/S Publishes Q2-2024 Report: Record Revenue and First-Ever Positive EBITDA

Press release from Companies: DanCann Pharma A/S announces last day for trading in temporary shares

Press release from Companies: DanCann Pharma A/S announces last day for trading in temporary shares

Press release from Companies: DanCann Pharma A/S announces outcome of the Rights Issue